Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in Thai population

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Posuwan, Nawarat ^a,b   Payungporn, Sunchai ^b   Tangkijvanich, Pisit ^b   Ogawa, Shintaro ^a   Murakami, Shuko ^a   Iijima, Sayuki ^a   Matsuura, Kentaro ^a   Shinkai, Noboru ^a   Watanabe, Tsunamasa ^a   Poovorawan, Yong ^b   Tanaka, Yasuhito ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; EHMT2 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HLA DPA1 GENE; HLA DPB1 GENE; HOMOZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TCF19 GENE; THAILAND; VIRUS CARRIER;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HEPATITIS B, CHRONIC; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HLA-DP ALPHA-CHAINS; HLA-DP BETA-CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THAILAND;

EID: 84899798113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086007     Document Type: Article

References (40)

1. Kao JH, Chen DS (2002) Global control of hepatitis B virus infection. Lancet Infect Dis 2: 395-403.
2. Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26: 6266-6273.
3. Dandri M, Locarnini S (2012) New insight in the pathobiology of hepatitis B virus infection. Gut 61 Suppl 1: i6-17.
4. Pan CQ, Zhang JX (2005) Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci 2: 36-40. (Pubitemid 40944951)
5. Tran TT, Martin P (2004) Hepatitis B: epidemiology and natural history. Clin Liver Dis 8: 255-266. (Pubitemid 38748603)
6. Pumpens P, Grens E, Nassal M (2002) Molecular epidemiology and immunology of hepatitis B virus infection - an update. Intervirology 45: 218-232. (Pubitemid 36173430)
7. Elgouhari HM, Abu-Rajab Tamimi TI, Carey WD (2008) Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med 75: 881-889.
8. Singh R, Kaul R, Kaul A, Khan K (2007) A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 13: 1770-1787. (Pubitemid 46706009)
9. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, et al. (2003) Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77: 12083-12087. (Pubitemid 37345173)
10. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-595.
11. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, et al. (2011) A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 20: 3884-3892.
12. Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, et al. (2011) Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One 6: e17608.
13. An P, Winkler C, Guan L, O'Brien SJ, Zeng Z, Consortium HBVS (2011) A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis 203: 943-947.
14. Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, et al. (2012) Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One 7: e39175.
15. Hu L, Zhai X, Liu J, Chu M, Pan S, et al. (2012) Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55: 1426-1431.
16. Kim YJ, Young Kim H, Lee JH, Jong Yu S, Yoon JH, et al. (2013) A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet: In press.
17. Ku DH, Chang CD, Koniecki J, Cannizzaro LA, Boghosian-Sell L, et al. (1991) A new growth-regulated complementary DNA with the sequence of a putative trans-activating factor. Cell Growth Differ 2: 179-186.
18. Shinkai Y, Tachibana M (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25: 781-788.
19. Tachibana M, Sugimoto K, Fukushima T, Shinkai Y (2001) Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276: 25309-25317.
20. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
21. Prokunina L, Alarcon-Riquelme ME (2004) Regulatory SNPs in complex diseases: their identification and functional validation. Expert Rev Mol Med 6: 1-15.
22. Yang PL, Althage A, Chung J, Maier H, Wieland S, et al. (2010) Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 107: 798-802.
23. O'Brien TR, Kohaar I, Pfeiffer RM, Maeder D, Yeager M, et al. (2011) Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun 12: 428-433.
24. Miller GM, Madras BK (2002) Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7: 44-55. (Pubitemid 34087878)
25. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, et al. (2002) A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70: 806-812. (Pubitemid 34177937)
26. Ferreira MA, Hottenga JJ, Warrington NM, Medland SE, Willemsen G, et al. (2009) Sequence variants in three loci influence monocyte counts and erythrocyte volume. Am J Hum Genet 85: 745-749.
27. Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, et al. (2011) Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 13: 676-684.
28. Albert M, Helin K (2010) Histone methyltransferases in cancer. Semin Cell Dev Biol 21: 209-220.
29. Krivtsov AV, Armstrong SA (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7: 823-833. (Pubitemid 350006257)
30. Lu Z, Tian Y, Salwen HR, Chlenski A, Godley LA, et al. (2013) Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Anticancer Drugs 24: 484-493.
31. Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, el at. (2011) A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet 20: 3893-3898.
32. Thomas R, Thio CL, Apps R, Qi Y, Gao X, et al. (2012) A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 86: 6979-6985.
33. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, et al. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472: 495-498.
34. Guo X, Zhang Y, Li J, Ma J, Wei Z, et al. (2011) Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 53: 422-428.
35. Yan Z, Tan S, Dan Y, Sun X, Deng G, et al. (2012) Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis. Infect Genet Evol 12: 1222-1228.
36. Vermehren J, Lotsch J, Susser S, Wicker S, Berger A, et al. (2012) A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS One 7: e32605.
37. Zeng G, Wang Z, Wen S, Jiang J, Wang L, et al. (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12: 609-617. (Pubitemid 41532492)
38. Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20: 992-1000.
39. Li J, Yang D, He Y, Wang M, Wen Z, et al. (2011) Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One 6: e24221.
40. Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, et al. (2013) Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One 8: e66920.